Cargando…
15 Years of Experience with Biphasic Insulin Aspart 30 in Type 2 Diabetes
Since clinical experience with biphasic insulin aspart 30 (BIAsp 30) in type 2 diabetes mellitus (T2DM) was reviewed in 2012 after 10 years of use worldwide, additional studies have been published that highlight new aspects, including use in real-world populations. Evidence from 35 new studies confi...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833912/ https://www.ncbi.nlm.nih.gov/pubmed/29468559 http://dx.doi.org/10.1007/s40268-018-0228-x |